Logo

Synapse Signs an Agreement with Pfizer in Oncology Precision Medicine

Share this

Synapse Signs an Agreement with Pfizer in Oncology Precision Medicine

Shots:

  • Pfizer and Synapse collaborate to advance the cancer outcomes research using real-world evidence and accelerate new cancer therapies for the improvement of patient’s health with an initial focus on molecular testing and therapy choices in precision oncology in the healthcare
  • The focus of the collaboration is to better understand the treatments for people living with cancer and develop evidence-based insights to improve cancer outcomes
  • Syapse’s insights platform- data sharing network and industrial partnerships bring leading healthcare innovators into a unified ecosystem providing access to personalized care regardless of location or income

Click here to­ read full press release/ article | Ref: Globe Newswire | Image: Chicago Tribune


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions